Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications

Pyrido[2,3-<i>d</i>]pyrimidines (<b>1</b>) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-<i>d</i>]pyrimidi...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Guillem Jubete, Raimon Puig de la Bellacasa, Roger Estrada-Tejedor, Jordi Teixidó, José I. Borrell
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/22/4161
_version_ 1852781045215133696
author Guillem Jubete
Raimon Puig de la Bellacasa
Roger Estrada-Tejedor
Jordi Teixidó
José I. Borrell
author_facet Guillem Jubete
Raimon Puig de la Bellacasa
Roger Estrada-Tejedor
Jordi Teixidó
José I. Borrell
author_sort Guillem Jubete
collection DOAJ
container_title Molecules
description Pyrido[2,3-<i>d</i>]pyrimidines (<b>1</b>) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>) due to the similitude with nitrogen bases present in DNA and RNA. Currently there are more than 20,000 structures <b>2</b> described which correspond to around 2900 references (half of them being patents). Furthermore, the number of references containing compounds of general structure <b>2</b> have increased almost exponentially in the last 10 years. The present review covers the synthetic methods used for the synthesis of pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>), both starting from a preformed pyrimidine ring or a pyridine ring, and the biomedical applications of such compounds.
format Article
id doaj-art-3259d4a1ccd1415ca2b2a4e84df3ee5c
institution Directory of Open Access Journals
issn 1420-3049
language English
publishDate 2019-11-01
publisher MDPI AG
record_format Article
spelling doaj-art-3259d4a1ccd1415ca2b2a4e84df3ee5c2025-08-19T20:48:00ZengMDPI AGMolecules1420-30492019-11-012422416110.3390/molecules24224161molecules24224161Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical ApplicationsGuillem Jubete0Raimon Puig de la Bellacasa1Roger Estrada-Tejedor2Jordi Teixidó3José I. Borrell4Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainGrup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, SpainPyrido[2,3-<i>d</i>]pyrimidines (<b>1</b>) are a type of privileged heterocyclic scaffolds capable of providing ligands for several receptors in the body. Among such structures, our group and others have been particularly interested in pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>) due to the similitude with nitrogen bases present in DNA and RNA. Currently there are more than 20,000 structures <b>2</b> described which correspond to around 2900 references (half of them being patents). Furthermore, the number of references containing compounds of general structure <b>2</b> have increased almost exponentially in the last 10 years. The present review covers the synthetic methods used for the synthesis of pyrido[2,3-<i>d</i>]pyrimidine-7(8<i>H</i>)-ones (<b>2</b>), both starting from a preformed pyrimidine ring or a pyridine ring, and the biomedical applications of such compounds.https://www.mdpi.com/1420-3049/24/22/4161pyrido[2,3-<i>d</i>]pyrimidines5,6-dihydropyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-onesbiological activitysubstitution pattern
spellingShingle Guillem Jubete
Raimon Puig de la Bellacasa
Roger Estrada-Tejedor
Jordi Teixidó
José I. Borrell
Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
pyrido[2,3-<i>d</i>]pyrimidines
5,6-dihydropyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-ones
biological activity
substitution pattern
title Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
title_full Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
title_fullStr Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
title_full_unstemmed Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
title_short Pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones: Synthesis and Biomedical Applications
title_sort pyrido 2 3 i d i pyrimidin 7 8 i h i ones synthesis and biomedical applications
topic pyrido[2,3-<i>d</i>]pyrimidines
5,6-dihydropyrido[2,3-<i>d</i>]pyrimidin-7(8<i>h</i>)-ones
biological activity
substitution pattern
url https://www.mdpi.com/1420-3049/24/22/4161
work_keys_str_mv AT guillemjubete pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications
AT raimonpuigdelabellacasa pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications
AT rogerestradatejedor pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications
AT jorditeixido pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications
AT joseiborrell pyrido23idipyrimidin78ihionessynthesisandbiomedicalapplications